These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 872145
1. Comparative antitumor effects of peptichemio and other alkylating agents. Schmid FA, Banks SE, Stock CC. Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145 [No Abstract] [Full Text] [Related]
2. [Experimental study of the antitumor activity and toxicity of the preparation, Peptichemio]. Balitskiĭ KP, Veksler IG, Tsapenko VF. Vopr Onkol; 1979; 25(7):105. PubMed ID: 483671 [No Abstract] [Full Text] [Related]
3. [Action of a synthetic peptide on some syngeneic tumors]. Pugliese A, Negro Ponzi A. G Batteriol Virol Immunol; 1975; 68(7-12):231-9. PubMed ID: 1234591 [Abstract] [Full Text] [Related]
5. The role of WR-2721 in radiotherapy and/or chemotherapy. Yuhas JM, Spellman JM, Culo F. Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681 [Abstract] [Full Text] [Related]
6. The need for additional alkylating agents. Connors TA. Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691 [No Abstract] [Full Text] [Related]
7. [Comparative characteristics of the toxicity and antitumor activity of a number of haloid derivatives of embikhin and Nor HN2]. Demirchoglian IG, Babasian OV, Galstian DA. Zh Eksp Klin Med; 1979 Dec; 19(5):46-52. PubMed ID: 525103 [No Abstract] [Full Text] [Related]
8. [Quantitative evaluation of the efficacy of antineoplastic agents]. Karavainova MKh. Farmakol Toksikol; 1971 Dec; 34(5):618-21. PubMed ID: 5004886 [No Abstract] [Full Text] [Related]
10. [Peptichemio--a new anti-blastic drug]. Prusek W. Postepy Hig Med Dosw; 1977 Dec; 31(6):833-54. PubMed ID: 604985 [No Abstract] [Full Text] [Related]
11. [Effects of a synthetic peptide on the cytotoxic activity of the lymphocytes of animals with tumors]. Landolfo S, Pugliese A. G Batteriol Virol Immunol; 1975 Dec; 68(7-12):240-6. PubMed ID: 1234592 [Abstract] [Full Text] [Related]
13. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. Geran RI, Congleton GF, Dudeck LE, Abbott BJ, Gargus JL. Cancer Chemother Rep 2; 1974 Dec; 4(4):53-87. PubMed ID: 4447935 [No Abstract] [Full Text] [Related]
14. [Selectivity of the antitumor action of 2 alkylating compounds with different carrier structures]. Astardzhieva Z, Stoichkov I. Eksp Med Morfol; 1988 Dec; 27(2):14-7. PubMed ID: 3168903 [No Abstract] [Full Text] [Related]
15. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations]. Kulik GI. Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230 [No Abstract] [Full Text] [Related]
16. Ultrastructural aspects of Peptichemio action on mouse sarcoma 180. Castano P. Boll Ist Sieroter Milan; 1976 Sep 30; 55(4):345-52. PubMed ID: 1016588 [Abstract] [Full Text] [Related]
18. Peptichemio in children with neoplastic disease. Mori PG, Comelli A, Pasino M, Correra A, Massimo L. An Esp Pediatr; 1976 Dec 30; 9(9):76-83. PubMed ID: 797281 [Abstract] [Full Text] [Related]
19. [The significance of connective tissue stimulation in antitumor chemotherapy]. Diadosha GF, Bulkina ZP, Kononenko LI. Vopr Onkol; 1968 Dec 30; 14(9):70-3. PubMed ID: 4971964 [No Abstract] [Full Text] [Related]